NO146060C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-substituerte-5-alkylresorcinol - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-substituerte-5-alkylresorcinolInfo
- Publication number
- NO146060C NO146060C NO763881A NO763881A NO146060C NO 146060 C NO146060 C NO 146060C NO 763881 A NO763881 A NO 763881A NO 763881 A NO763881 A NO 763881A NO 146060 C NO146060 C NO 146060C
- Authority
- NO
- Norway
- Prior art keywords
- substituted
- preparation
- therapeutic active
- alkyl resorcinol
- analogy procedure
- Prior art date
Links
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 title 2
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
- C07C45/66—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups by dehydration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/794—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring
- C07C49/796—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/632,126 US4018777A (en) | 1975-11-14 | 1975-11-14 | 2-Substituted-5-alkyl resorcinols |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO763881L NO763881L (fr) | 1977-05-18 |
| NO146060B NO146060B (no) | 1982-04-13 |
| NO146060C true NO146060C (no) | 1982-08-04 |
Family
ID=24534181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO763881A NO146060C (no) | 1975-11-14 | 1976-11-12 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-substituerte-5-alkylresorcinol |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4018777A (fr) |
| JP (1) | JPS5262254A (fr) |
| AU (1) | AU511431B2 (fr) |
| CA (1) | CA1090346A (fr) |
| CH (1) | CH618427A5 (fr) |
| DE (1) | DE2651708A1 (fr) |
| DK (1) | DK506776A (fr) |
| FI (1) | FI763241A (fr) |
| FR (2) | FR2361887A1 (fr) |
| GB (1) | GB1541858A (fr) |
| GR (1) | GR61763B (fr) |
| MX (1) | MX4120E (fr) |
| NL (1) | NL7612607A (fr) |
| NO (1) | NO146060C (fr) |
| PH (1) | PH12341A (fr) |
| PT (1) | PT65816B (fr) |
| SE (1) | SE428800B (fr) |
| ZA (1) | ZA766571B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6566560B2 (en) | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
| WO2002026224A2 (fr) * | 2000-09-28 | 2002-04-04 | Immugen Pharmaceuticals, Inc. | Procedes et composes pour inhiber le metabolisme des eicosanoides et l'agregation plaquettaire |
| WO2002026728A2 (fr) * | 2000-09-28 | 2002-04-04 | Immugen Pharmaceuticals, Inc. | Procedes antiviraux et composes |
| CN1652766A (zh) * | 2002-03-18 | 2005-08-10 | 免疫力药品有限公司 | 间苯二酚和大麻素的局部制剂及其施用方法 |
| CA2496097A1 (fr) * | 2002-08-23 | 2004-03-04 | University Of Connecticut | Ceto-cannabinoides possedant des indications therapeutiques |
| CA2495903A1 (fr) * | 2002-08-23 | 2004-03-04 | University Of Connecticut | Nouveaux cannabinoides biphenyle et de type biphenyle |
| JP5654608B2 (ja) * | 2009-11-17 | 2015-01-14 | ノバルティス アーゲー | アルドステロンシンターゼ阻害剤としてのアリール−ピリジン誘導体 |
| KR20200004792A (ko) * | 2017-05-09 | 2020-01-14 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 피라노디피리딘 화합물의 결정 |
| WO2020185661A1 (fr) * | 2019-03-08 | 2020-09-17 | The Regents Of The University Of California | Utilisation de composés de 8,9-dihydrocannabidiol |
| CA3132861A1 (fr) * | 2019-03-12 | 2020-09-17 | 6th Wave Innovations Corp. | Polymeres a empreinte moleculaire pour l'extraction de cannabinoides et utilisations associees |
| EP4251600A2 (fr) | 2020-11-24 | 2023-10-04 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Dérivés cannabinoïdes et leur utilisation dans le traitement de l'inflammation et/ou de la douleur et/ou de l'obésité |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3901926A (en) * | 1973-04-02 | 1975-08-26 | Abbott Lab | Alkylphenyl benzopyrans |
-
1975
- 1975-11-14 US US05/632,126 patent/US4018777A/en not_active Expired - Lifetime
-
1976
- 1976-11-02 ZA ZA766571A patent/ZA766571B/xx unknown
- 1976-11-08 CA CA265,182A patent/CA1090346A/fr not_active Expired
- 1976-11-09 FR FR7633756A patent/FR2361887A1/fr active Granted
- 1976-11-10 DK DK506776A patent/DK506776A/da not_active Application Discontinuation
- 1976-11-10 MX MX765115U patent/MX4120E/es unknown
- 1976-11-10 PT PT65816A patent/PT65816B/pt unknown
- 1976-11-10 JP JP51134255A patent/JPS5262254A/ja active Pending
- 1976-11-10 PH PH7619113A patent/PH12341A/en unknown
- 1976-11-11 SE SE7612620A patent/SE428800B/xx unknown
- 1976-11-11 GR GR52161A patent/GR61763B/el unknown
- 1976-11-11 FI FI763241A patent/FI763241A/fi not_active Application Discontinuation
- 1976-11-12 NO NO763881A patent/NO146060C/no unknown
- 1976-11-12 GB GB47323/76A patent/GB1541858A/en not_active Expired
- 1976-11-12 NL NL7612607A patent/NL7612607A/xx not_active Application Discontinuation
- 1976-11-12 DE DE19762651708 patent/DE2651708A1/de active Pending
- 1976-11-12 CH CH1431076A patent/CH618427A5/fr not_active IP Right Cessation
-
1977
- 1977-01-07 AU AU21148/77A patent/AU511431B2/en not_active Expired
- 1977-05-05 FR FR7713746A patent/FR2397385A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ZA766571B (en) | 1977-10-26 |
| FR2397385A1 (fr) | 1979-02-09 |
| SE428800B (sv) | 1983-07-25 |
| SE7612620L (sv) | 1977-05-15 |
| DK506776A (da) | 1977-05-15 |
| NO146060B (no) | 1982-04-13 |
| JPS5262254A (en) | 1977-05-23 |
| AU511431B2 (en) | 1980-08-21 |
| FR2397385B1 (fr) | 1980-04-25 |
| FI763241A (fr) | 1977-05-15 |
| PT65816B (en) | 1978-05-12 |
| PT65816A (en) | 1976-12-01 |
| CH618427A5 (fr) | 1980-07-31 |
| NO763881L (fr) | 1977-05-18 |
| MX4120E (es) | 1981-12-15 |
| NL7612607A (nl) | 1977-05-17 |
| CA1090346A (fr) | 1980-11-25 |
| FR2361887B1 (fr) | 1979-03-09 |
| DE2651708A1 (de) | 1977-05-18 |
| PH12341A (en) | 1979-01-16 |
| AU2114877A (en) | 1978-07-13 |
| GB1541858A (en) | 1979-03-07 |
| FR2361887A1 (fr) | 1978-03-17 |
| US4018777A (en) | 1977-04-19 |
| GR61763B (en) | 1979-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO149962C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater | |
| NO150800C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tricykliske forbindelser | |
| NO148712C (no) | Fremgangsmaate ved fremstilling av etylidendiacetat | |
| NO800858L (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater | |
| NO145379C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider. | |
| NO151040C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner | |
| NO146095C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater | |
| NO147953C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider | |
| NO143796C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme piperazinyliminorifamyciner | |
| NO145791C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater | |
| NO146359C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater | |
| NO145236C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive omega-aminocarboxylsyrederivater | |
| NO146060C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-substituerte-5-alkylresorcinol | |
| NO149737C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer | |
| NO149313C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
| NO151239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner | |
| NO149037C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
| NO146571C (no) | Analogifremgangsmaate ved fremstilling av anti-inflammatorisk aktive imidazoler | |
| NO147150C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperidiner. | |
| NO143664C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive dibenzofuranforbindelser | |
| NO145620C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive depotsteroidestere. | |
| NO144457C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner | |
| NO145163C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider | |
| NO147485C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater | |
| NO146863C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer |